Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27073302 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Faizul Azam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Drug Design, Artificial Intelligence. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 267 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Graduate Studies and Scientific Research at Qassim University.
Abstract (Originalsprache)
Molecular docking is a foundational technique in computational drug discovery, widely used to generate binding hypotheses, prioritize compounds, and support target-selectivity studies. The continued growth of open-source docking resources, together with improvements in scoring functions, sampling strategies, and hardware acceleration, has substantially lowered barriers to teaching, early-stage hit identification, and reproducible research. Beyond standalone docking engines, the open-source ecosystem now encompasses browser-accessible tools, preparation and analysis utilities, integrative modeling platforms, and AI-augmented methods for pose prediction, rescoring, and virtual screening. These developments have made docking workflows more accessible, customizable, and transparent across diverse research settings. This review examines open-source docking from a workflow-centered perspective, spanning study design, structural-data acquisition, binding-site definition, receptor and ligand preparation, docking execution, and post-docking validation. It further evaluates how open AI methods are being incorporated into these stages to expand structural coverage, improve screening efficiency, and support contemporary structure-based drug design. Collectively, this review outlines a practical and evidence-based framework for the effective use of open-source docking and virtual-screening pipelines in modern drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
ORCID-Profile: Faizul Azam
Förderung
- Deanship of Graduate Studies and Scientific Research at Qassim University
Zitieren
APA
Azam, F., & Almahmoud, S. A. (2026). Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073302
Vancouver
Azam F, Almahmoud SA. Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073302
BibTeX
@article{Azam2026,
author = {Azam, Faizul and Almahmoud, Suliman A},
title = {Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27073302}
}
EUVIMED